← Every applicant

Aurobindo Pharma FDA Approvals

66 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
BRIVARACETAMNew drugAug 10, 2026SOLUTION, ORAL
VANCOMYCIN HYDROCHLORIDENew drugAug 7, 2026FOR SOLUTION, ORAL
ESLICARBAZEPINE ACETATENew drugAug 5, 2026TABLET, ORAL
CEPHALEXINNew drugJun 9, 2026FOR SUSPENSION, ORAL
ELUXADOLINENew drugJun 2, 2026TABLET, ORAL
PIRFENIDONENew drugApr 20, 2026CAPSULE, ORAL
GLYCEROL PHENYLBUTYRATENew drugApr 15, 2026LIQUID
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDENew drugApr 6, 2026TABLET
DAPAGLIFLOZINNew drugApr 6, 2026TABLET, ORAL
ARIPIPRAZOLENew drugFeb 18, 2026TABLET, ORALLY DISINTEGRATING, ORAL
LOPERAMIDE HYDROCHLORIDENew drugDec 29, 2025CAPSULE, ORAL
POTASSIUM CHLORIDENew drugNov 20, 2025SOLUTION, ORAL
NAPROXENNew drugOct 3, 2025SUSPENSION, ORAL
DEFERASIROXNew drugSep 8, 2025GRANULE, ORAL
PIRFENIDONENew drugAug 11, 2025TABLET, ORAL
SAPROPTERIN DIHYDROCHLORIDENew drugJun 9, 2025TABLET, ORAL
DABIGATRAN ETEXILATE MESYLATENew drugMay 14, 2025CAPSULE, ORAL
VARENICLINE TARTRATENew drugMay 2, 2025TABLET, ORAL
NYSTATINNew drugMar 21, 2025CREAM, TOPICAL
AZELASTINE HYDROCHLORIDE ALLERGYNew drugJan 27, 2025SPRAY, METERED, NASAL
CLOZAPINENew drugDec 12, 2024TABLET, ORALLY DISINTEGRATING, ORAL
MOMETASONE FUROATENew drugNov 22, 2024SPRAY, METERED, NASAL
METFORMIN HYDROCHLORIDENew drugOct 18, 2024TABLET, EXTENDED RELEASE, ORAL
ESTRADIOLNew drugAug 2, 2024TABLET, VAGINAL
POSACONAZOLENew drugJul 18, 2024TABLET, DELAYED RELEASE, ORAL
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDENew drugJul 18, 2024CAPSULE, ORAL
LEVOTHYROXINE SODIUMNew drugJul 16, 2024TABLET, ORAL
MINOXIDIL (FOR WOMEN)New drugApr 22, 2024AEROSOL, FOAM, TOPICAL
DESMOPRESSIN ACETATENew drugMar 21, 2024TABLET, ORAL
MOMETASONE FUROATENew drugMar 18, 2024SPRAY, METERED, NASAL
MYCOPHENOLATE MOFETILNew drugFeb 20, 2024TABLET, ORAL
ISOTRETINOINNew drugJan 29, 2024CAPSULE, ORAL
ENALAPRIL MALEATENew drugJan 8, 2024SOLUTION, ORAL
OSHIHNew drugDec 6, 2023TABLET, ORAL
ZAFIRLUKASTNew drugNov 27, 2023TABLET, ORAL
AMPICILLIN TRIHYDRATENew drugOct 31, 2023CAPSULE, ORAL
NITROGLYCERINNew drugOct 26, 2023TABLET, SUBLINGUAL
SAXAGLIPTINNew drugJul 31, 2023TABLET, ORAL
RUFINAMIDENew drugJun 16, 2023TABLET, ORAL
SAFINAMIDE MESYLATENew drugJun 14, 2023TABLET, ORAL
NITROFURANTOINNew drugMay 11, 2023SUSPENSION, ORAL
PHENOXYBENZAMINE HYDROCHLORIDENew drugMay 8, 2023CAPSULE, ORAL
CEVIMELINE HYDROCHLORIDENew drugApr 18, 2023CAPSULE, ORAL
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)New drugMar 30, 2023CAPSULE, ORAL
PREGABALINNew drugMar 29, 2023CAPSULE, ORAL
LORATADINENew drugMar 24, 2023CAPSULE, ORAL
CLOMIPRAMINE HYDROCHLORIDENew drugMar 20, 2023CAPSULE, ORAL
LINACLOTIDENew drugFeb 7, 2023CAPSULE, ORAL
EMZAHHNew drugJan 6, 2023TABLET, ORAL-28
SOLIFENACIN SUCCINATENew drugDec 27, 2022TABLET, ORAL
RANOLAZINENew drugDec 23, 2022TABLET, EXTENDED RELEASE, ORAL
DIMETHYL FUMARATENew drugDec 22, 2022CAPSULE, DELAYED RELEASE, ORAL
VALGANCICLOVIR HYDROCHLORIDENew drugNov 17, 2022FOR SOLUTION, ORAL
ISOSORBIDE MONONITRATENew drugNov 7, 2022TABLET, EXTENDED RELEASE, ORAL
RUFINAMIDENew drugOct 26, 2022SUSPENSION, ORAL
RHUZDAHNew drugOct 11, 2022TABLET, ORAL-28
FENOFIBRATENew drugSep 27, 2022TABLET, ORAL
AMINOCAPROIC ACIDNew drugSep 26, 2022SOLUTION, ORAL
DICLOXACILLIN SODIUMNew drugSep 23, 2022CAPSULE, ORAL
AMBRISENTANNew drugJul 21, 2022TABLET, ORAL
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDENew drugJun 1, 2022TABLET, EXTENDED RELEASE, ORAL
IBUPROFEN AND DIPHENHYDRAMINE CITRATENew drugMay 31, 2022TABLET, ORAL
ACYCLOVIRNew drugMar 31, 2022SUSPENSION, ORAL
NICOTINE POLACRILEXNew drugAug 3, 2021TROCHE/LOZENGE, ORAL
NIFEDIPINENew drugJul 19, 2021TABLET, EXTENDED RELEASE, ORAL
LEFLUNOMIDENew drugMar 29, 2021TABLET, ORAL

Related datasets